Usability, acceptability, and cost of the SD BIOLINE Ov16 rapid diagnostic test for onchocerciasis surveillance in endemic communities in the middle belt of Ghana
Ov16 RDT is more acceptable and affordable (a third of the cost) compared to skin-snipping for surveillance activities in transmission hotspots in Ghana.
Authors
- Andrews Agyapong Boakye
- Prince Nyarko (ORCID: https://orcid.org/0009-0008-9233-6367)
- Robert Colebunders (ORCID: https://orcid.org/0000-0002-1919-1340)
- Michael Ntiamoah Oppong (ORCID: https://orcid.org/0000-0001-9482-4438)
- Marı́a-Gloria Basáñez (ORCID: https://orcid.org/0000-0001-5031-3361)
- Henk D. F. H. Schallig (ORCID: https://orcid.org/0000-0002-7096-6279)
- Kenneth Bentum Otabil (ORCID: https://orcid.org/0000-0002-2758-0805)
- Michael Tawiah Yeboah
- Emmanuel John Bart‐Plange
- Theophilus Nti Babae
- Lydia Datsa
- Prince Charles Kudzordzi (ORCID: https://orcid.org/0009-0008-8145-3488)
- Edwina Twum Blay
- Richmond Gyasi-Ampofo
- Anabel Acheampong (ORCID: https://orcid.org/0009-0008-1676-8678)
- Prince Mensah
- Elizabeth Ameyaa
Institutions
- University of Antwerp (BE)
- Liverpool School of Tropical Medicine (GB)
- Amsterdam UMC Location University of Amsterdam (NL)
- University of Energy and Natural Resources (GH)
- Amsterdam Institute for Global Health and Development (NL)
- Kintampo Health Research Centre (GH)
- Ghana Health Service (GH)
- London Centre for Neglected Tropical Disease Research (GB)
- Sunyani Technical University (GH)
- University of Amsterdam (NL)
Publication Details
- Journal
- PLoS neglected tropical diseases
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1371/journal.pntd.0012191
- Primary Topic
- Parasitic Diseases Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- United States Agency for International Development
- Royal Society of Tropical Medicine and Hygiene
- Fonds Wetenschappelijk Onderzoek
- Vlaamse regering
- Foreign, Commonwealth and Development Office
- Medical Research Council
- European and Developing Countries Clinical Trials Partnership